| Eli Lilly (Suisse) SA - Adcirca, comprimés pelliculés | | 62169 | | 01 | | Adcirca | | comprimés pelliculés | | G04BE08 | | Tadalafil | | 08.11.2011 | | |
| | Composition | | tadalafilum 20 mg, lactosum monohydricum 245.195 mg, hydroxypropylcellulosum, carmellosum natricum conexum, natrii laurilsulfas, cellulosum microcristallinum, magnesii stearas, pellicule: lactosum monohydricum 5.599 mg, hypromellosum, triacetinum, E 171, E 172 (flavum), E 172 (rubrum), talcum, pro compresso obducto corresp. natrium max. 2.09 mg. | | Packungsbestandteile | | Coated tablets | | | | | | BAG: Active Agent | Dose |
|---|
| | 20 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | | | Hypromellosum | | | | Lactose Monohydrate | 5.599 mg | pellicule | | | | | | | | | | | | | | Talcum | | | | | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 56 Tablet(s) | 505.60 | 563.15 | B | SL | No |
|
|
